Report Detail

A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging.

Scope of the Report:
The worldwide market for Interventional X-ray Contrast and Imaging Agents is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Interventional X-ray Contrast and Imaging Agents in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Bracco
General Electric
Guerbet
Fujifilm Visualsonics
Imax
J.B. Chemicals & Pharmaceuticals
Jodas Expoim
Lantheus Medical Imaging
Nano Therapeutics
Novalek Pharmaceuticals
Taejoon Pharm
Unijules Life Sciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Iodinated Contrast Media
Barium-Based Contrast Media
Microbubble Contrast Media
Other

Market Segment by Applications, can be divided into
Heart Disease
Neurological
Urology
General Surgery
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Interventional X-ray Contrast and Imaging Agents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Interventional X-ray Contrast and Imaging Agents, with price, sales, revenue and global market share of Interventional X-ray Contrast and Imaging Agents in 2017 and 2018.
Chapter 3, the Interventional X-ray Contrast and Imaging Agents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Interventional X-ray Contrast and Imaging Agents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Interventional X-ray Contrast and Imaging Agents market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Interventional X-ray Contrast and Imaging Agents sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Interventional X-ray Contrast and Imaging Agents Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Iodinated Contrast Media
      • 1.2.2 Barium-Based Contrast Media
      • 1.2.3 Microbubble Contrast Media
      • 1.2.4 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Heart Disease
      • 1.3.2 Neurological
      • 1.3.3 Urology
      • 1.3.4 General Surgery
      • 1.3.5 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Bracco
      • 2.1.1 Business Overview
      • 2.1.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 General Electric
      • 2.2.1 Business Overview
      • 2.2.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 General Electric Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Guerbet
      • 2.3.1 Business Overview
      • 2.3.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Fujifilm Visualsonics
      • 2.4.1 Business Overview
      • 2.4.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Imax
      • 2.5.1 Business Overview
      • 2.5.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Imax Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 J.B. Chemicals & Pharmaceuticals
      • 2.6.1 Business Overview
      • 2.6.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Jodas Expoim
      • 2.7.1 Business Overview
      • 2.7.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Lantheus Medical Imaging
      • 2.8.1 Business Overview
      • 2.8.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Nano Therapeutics
      • 2.9.1 Business Overview
      • 2.9.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Novalek Pharmaceuticals
      • 2.10.1 Business Overview
      • 2.10.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Taejoon Pharm
      • 2.11.1 Business Overview
      • 2.11.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Unijules Life Sciences
      • 2.12.1 Business Overview
      • 2.12.2 Interventional X-ray Contrast and Imaging Agents Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Interventional X-ray Contrast and Imaging Agents Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Interventional X-ray Contrast and Imaging Agents Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Interventional X-ray Contrast and Imaging Agents Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Interventional X-ray Contrast and Imaging Agents Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Interventional X-ray Contrast and Imaging Agents Market Analysis by Regions

    • 4.1 Global Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Interventional X-ray Contrast and Imaging Agents Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 4.3 Europe Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 4.5 South America Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)

    5 North America Interventional X-ray Contrast and Imaging Agents by Country

    • 5.1 North America Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Market Share by Country
      • 5.1.1 North America Interventional X-ray Contrast and Imaging Agents Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Interventional X-ray Contrast and Imaging Agents Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 5.3 Canada Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)

    6 Europe Interventional X-ray Contrast and Imaging Agents by Country

    • 6.1 Europe Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Interventional X-ray Contrast and Imaging Agents Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 6.3 UK Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 6.4 France Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 6.5 Russia Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 6.6 Italy Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Interventional X-ray Contrast and Imaging Agents by Country

    • 7.1 Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Interventional X-ray Contrast and Imaging Agents Revenue and Market Share by Country (2014-2019)
    • 7.2 China Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 7.3 Japan Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 7.4 Korea Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 7.5 India Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)

    8 South America Interventional X-ray Contrast and Imaging Agents by Country

    • 8.1 South America Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Market Share by Country
      • 8.1.1 South America Interventional X-ray Contrast and Imaging Agents Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Interventional X-ray Contrast and Imaging Agents Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Interventional X-ray Contrast and Imaging Agents by Countries

    • 9.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Interventional X-ray Contrast and Imaging Agents Sales and Growth Rate (2014-2019)

    10 Global Interventional X-ray Contrast and Imaging Agents Market Segment by Type

    • 10.1 Global Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Interventional X-ray Contrast and Imaging Agents Revenue and Market Share by Type (2014-2019)
    • 10.2 Iodinated Contrast Media Sales Growth and Price
      • 10.2.1 Global Iodinated Contrast Media Sales Growth (2014-2019)
      • 10.2.2 Global Iodinated Contrast Media Price (2014-2019)
    • 10.3 Barium-Based Contrast Media Sales Growth and Price
      • 10.3.1 Global Barium-Based Contrast Media Sales Growth (2014-2019)
      • 10.3.2 Global Barium-Based Contrast Media Price (2014-2019)
    • 10.4 Microbubble Contrast Media Sales Growth and Price
      • 10.4.1 Global Microbubble Contrast Media Sales Growth (2014-2019)
      • 10.4.2 Global Microbubble Contrast Media Price (2014-2019)
    • 10.5 Other Sales Growth and Price
      • 10.5.1 Global Other Sales Growth (2014-2019)
      • 10.5.2 Global Other Price (2014-2019)

    11 Global Interventional X-ray Contrast and Imaging Agents Market Segment by Application

    • 11.1 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2014-2019)
    • 11.2 Heart Disease Sales Growth (2014-2019)
    • 11.3 Neurological Sales Growth (2014-2019)
    • 11.4 Urology Sales Growth (2014-2019)
    • 11.5 General Surgery Sales Growth (2014-2019)
    • 11.6 Other Sales Growth (2014-2019)

    12 Interventional X-ray Contrast and Imaging Agents Market Forecast (2019-2024)

    • 12.1 Global Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Interventional X-ray Contrast and Imaging Agents Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Interventional X-ray Contrast and Imaging Agents Market Forecast (2019-2024)
      • 12.2.2 Europe Interventional X-ray Contrast and Imaging Agents Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Interventional X-ray Contrast and Imaging Agents Market Forecast (2019-2024)
      • 12.2.4 South America Interventional X-ray Contrast and Imaging Agents Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Market Forecast (2019-2024)
    • 12.3 Interventional X-ray Contrast and Imaging Agents Market Forecast by Type (2019-2024)
      • 12.3.1 Global Interventional X-ray Contrast and Imaging Agents Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Interventional X-ray Contrast and Imaging Agents Market Share Forecast by Type (2019-2024)
    • 12.4 Interventional X-ray Contrast and Imaging Agents Market Forecast by Application (2019-2024)
      • 12.4.1 Global Interventional X-ray Contrast and Imaging Agents Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Interventional X-ray Contrast and Imaging Agents Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Interventional X-ray Contrast and Imaging Agents . Industry analysis & Market Report on Interventional X-ray Contrast and Imaging Agents is a syndicated market report, published as Global Interventional X-ray Contrast and Imaging Agents Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Interventional X-ray Contrast and Imaging Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,724.84
      4,087.26
      5,449.68
      3,205.08
      4,807.62
      6,410.16
      545,907.60
      818,861.40
      1,091,815.20
      289,362.00
      434,043.00
      578,724.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report